In addition, another IL‐6R human monoclonal antibody, Sarilumab, and an IL‐6 monoclonal antibody, Sirukumab, also shown therapeutic effects in RA, as demonstrated in the MOBILITY study.165. The gene discussed is IL6R; the disease is rheumatoid arthritis.